Related items

Authored by Malte Lohan, CEO, AmCham EU

On Wednesday, 27 May, AmCham EU hosted Paulina Dejmek Hack, Head of Cabinet for Jessika Roswall, Commissioner for Environment, European Commission, for a discussion on the upcoming Circular Economy Act. Moderated by Luca Ibelli (Procter & Gamble), Vice-Chair, Environment Committee, AmCham EU, the exchange explored how the Act can support Europe’s wider simplification agenda by reducing fragmentation and strengthening competitiveness. Participants also discussed the importance of a harmonised framework grounded in a clear business case, ensuring circular economy policies help companies operate effectively across the Single Market.

Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation. 

The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment. 

The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.